

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of RIG-I signaling pathway (GO:0039535) | 5.13722271 |
| 2 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.54350202 |
| 3 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.35252061 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.29844803 |
| 5 | mitotic metaphase plate congression (GO:0007080) | 4.29762484 |
| 6 | regulation of meiosis I (GO:0060631) | 4.28557123 |
| 7 | myoblast migration (GO:0051451) | 4.21497783 |
| 8 | meiotic chromosome segregation (GO:0045132) | 4.10061891 |
| 9 | negative regulation of hormone metabolic process (GO:0032351) | 4.08239534 |
| 10 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.08239534 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 3.96257370 |
| 12 | metaphase plate congression (GO:0051310) | 3.89005004 |
| 13 | positive regulation of p38MAPK cascade (GO:1900745) | 3.74296451 |
| 14 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.68656015 |
| 15 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.66494998 |
| 16 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.63009750 |
| 17 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.62863943 |
| 18 | regulation of meiosis (GO:0040020) | 3.62421843 |
| 19 | hemidesmosome assembly (GO:0031581) | 3.61865003 |
| 20 | regulation of histone H3-K27 methylation (GO:0061085) | 3.59837210 |
| 21 | establishment of chromosome localization (GO:0051303) | 3.57130738 |
| 22 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.53306968 |
| 23 | cell adhesion mediated by integrin (GO:0033627) | 3.51834530 |
| 24 | female gamete generation (GO:0007292) | 3.41176476 |
| 25 | regulation of vitamin metabolic process (GO:0030656) | 3.40810627 |
| 26 | negative regulation of meiosis (GO:0045835) | 3.38712593 |
| 27 | piRNA metabolic process (GO:0034587) | 3.35787020 |
| 28 | membrane raft organization (GO:0031579) | 3.35519489 |
| 29 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.34721826 |
| 30 | oocyte maturation (GO:0001556) | 3.33255113 |
| 31 | notochord development (GO:0030903) | 3.30444173 |
| 32 | regulation of female gonad development (GO:2000194) | 3.29686736 |
| 33 | protein K6-linked ubiquitination (GO:0085020) | 3.28668457 |
| 34 | meiotic cell cycle (GO:0051321) | 3.23139803 |
| 35 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.20631874 |
| 36 | DNA damage induced protein phosphorylation (GO:0006975) | 3.18399235 |
| 37 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.18332549 |
| 38 | protein localization to endosome (GO:0036010) | 3.16382359 |
| 39 | skin morphogenesis (GO:0043589) | 3.13884580 |
| 40 | mitotic chromosome condensation (GO:0007076) | 3.13567082 |
| 41 | maturation of 5.8S rRNA (GO:0000460) | 3.10834444 |
| 42 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.10090050 |
| 43 | regulation of exit from mitosis (GO:0007096) | 3.06229932 |
| 44 | cellular response to gamma radiation (GO:0071480) | 3.02339440 |
| 45 | nuclear pore complex assembly (GO:0051292) | 3.01149401 |
| 46 | response to peptidoglycan (GO:0032494) | 3.00965192 |
| 47 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.99591380 |
| 48 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.97064700 |
| 49 | regulation of meiotic cell cycle (GO:0051445) | 2.96152078 |
| 50 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.92141699 |
| 51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90539370 |
| 52 | response to muramyl dipeptide (GO:0032495) | 2.88091063 |
| 53 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.85779057 |
| 54 | response to laminar fluid shear stress (GO:0034616) | 2.85238937 |
| 55 | histone H2A monoubiquitination (GO:0035518) | 2.85236951 |
| 56 | regulation of establishment of cell polarity (GO:2000114) | 2.84941276 |
| 57 | regulation of spindle organization (GO:0090224) | 2.83213474 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79585207 |
| 59 | protein localization to chromosome, centromeric region (GO:0071459) | 2.79581057 |
| 60 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.79404655 |
| 61 | male meiosis (GO:0007140) | 2.78927185 |
| 62 | regulation of p38MAPK cascade (GO:1900744) | 2.78450416 |
| 63 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.76188213 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75242151 |
| 65 | natural killer cell mediated immunity (GO:0002228) | 2.74521244 |
| 66 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.74521244 |
| 67 | regulation of sister chromatid cohesion (GO:0007063) | 2.73764611 |
| 68 | regulation of keratinocyte differentiation (GO:0045616) | 2.71649767 |
| 69 | hypotonic response (GO:0006971) | 2.71323773 |
| 70 | Rap protein signal transduction (GO:0032486) | 2.69827792 |
| 71 | wound healing, spreading of cells (GO:0044319) | 2.67210507 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 2.66910612 |
| 73 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.66557612 |
| 74 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.66447336 |
| 75 | embryonic process involved in female pregnancy (GO:0060136) | 2.66304987 |
| 76 | regulation of mitotic spindle organization (GO:0060236) | 2.65924985 |
| 77 | CENP-A containing nucleosome assembly (GO:0034080) | 2.65648260 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.64984372 |
| 79 | type B pancreatic cell development (GO:0003323) | 2.64802294 |
| 80 | protein localization to kinetochore (GO:0034501) | 2.64338433 |
| 81 | chromatin remodeling at centromere (GO:0031055) | 2.63099580 |
| 82 | protein localization to chromosome (GO:0034502) | 2.62344337 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.62315984 |
| 84 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.61783240 |
| 85 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.61783240 |
| 86 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.61783240 |
| 87 | cellular response to arsenic-containing substance (GO:0071243) | 2.61681232 |
| 88 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61341192 |
| 89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.60509318 |
| 90 | activation of MAPKKK activity (GO:0000185) | 2.60488911 |
| 91 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.59381030 |
| 92 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59371989 |
| 93 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.59020363 |
| 94 | desmosome organization (GO:0002934) | 2.58010065 |
| 95 | establishment of endothelial barrier (GO:0061028) | 2.57880273 |
| 96 | sister chromatid cohesion (GO:0007062) | 2.56955226 |
| 97 | chromosome segregation (GO:0007059) | 2.56609608 |
| 98 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56386999 |
| 99 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.56370522 |
| 100 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.56370522 |
| 101 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56124182 |
| 102 | positive regulation of extracellular matrix organization (GO:1903055) | 2.55250362 |
| 103 | regulation of centriole replication (GO:0046599) | 2.51527064 |
| 104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51002573 |
| 105 | mitotic sister chromatid cohesion (GO:0007064) | 2.49028467 |
| 106 | negative regulation of meiotic cell cycle (GO:0051447) | 2.48972724 |
| 107 | regulation of chronic inflammatory response (GO:0002676) | 2.48202017 |
| 108 | mitotic G2/M transition checkpoint (GO:0044818) | 2.47407981 |
| 109 | keratinocyte proliferation (GO:0043616) | 2.46705490 |
| 110 | mitotic sister chromatid segregation (GO:0000070) | 2.46700610 |
| 111 | nuclear pore organization (GO:0006999) | 2.45928500 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.45782923 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.45782923 |
| 114 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.45606567 |
| 115 | mitotic nuclear envelope disassembly (GO:0007077) | 2.44404648 |
| 116 | cell-substrate junction assembly (GO:0007044) | 2.43612195 |
| 117 | mature B cell differentiation involved in immune response (GO:0002313) | 2.43607478 |
| 118 | response to type I interferon (GO:0034340) | 2.42982723 |
| 119 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.42291488 |
| 120 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.41248627 |
| 121 | immunoglobulin mediated immune response (GO:0016064) | 2.41233093 |
| 122 | positive regulation of interferon-alpha production (GO:0032727) | 2.40923860 |
| 123 | mRNA transcription (GO:0009299) | 2.40863727 |
| 124 | ovulation (GO:0030728) | 2.40713981 |
| 125 | * platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.39854887 |
| 126 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.39390772 |
| 127 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.39230028 |
| 128 | positive regulation of natural killer cell activation (GO:0032816) | 2.39105861 |
| 129 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.38387104 |
| 130 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.37942093 |
| 131 | response to progesterone (GO:0032570) | 2.37222920 |
| 132 | nuclear envelope disassembly (GO:0051081) | 2.37082173 |
| 133 | membrane disassembly (GO:0030397) | 2.37082173 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36850515 |
| 135 | parturition (GO:0007567) | 2.35778195 |
| 136 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.35694304 |
| 137 | N-terminal protein amino acid acetylation (GO:0006474) | 2.35688016 |
| 138 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.35208099 |
| 139 | superoxide anion generation (GO:0042554) | 2.34962511 |
| 140 | DNA replication-independent nucleosome organization (GO:0034724) | 2.34915368 |
| 141 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.34915368 |
| 142 | NIK/NF-kappaB signaling (GO:0038061) | 2.34581444 |
| 143 | ovulation from ovarian follicle (GO:0001542) | 2.34553984 |
| 144 | positive regulation of chromosome segregation (GO:0051984) | 2.34331599 |
| 145 | pore complex assembly (GO:0046931) | 2.33894442 |
| 146 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.33582718 |
| 147 | spindle checkpoint (GO:0031577) | 2.33469115 |
| 148 | response to protozoan (GO:0001562) | 2.33091965 |
| 149 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.32948345 |
| 150 | histone demethylation (GO:0016577) | 2.32372031 |
| 151 | centriole replication (GO:0007099) | 2.32164387 |
| 152 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.32131964 |
| 153 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.31677944 |
| 154 | positive regulation by symbiont of host defense response (GO:0052509) | 2.31166373 |
| 155 | modulation by symbiont of host defense response (GO:0052031) | 2.31166373 |
| 156 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.31166373 |
| 157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.31166373 |
| 158 | modulation by symbiont of host immune response (GO:0052553) | 2.31166373 |
| 159 | regulation of transforming growth factor beta production (GO:0071634) | 2.29285473 |
| 160 | germinal center formation (GO:0002467) | 2.28997895 |
| 161 | low-density lipoprotein particle clearance (GO:0034383) | 2.28948081 |
| 162 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.27295273 |
| 163 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.26761033 |
| 164 | negative regulation of anoikis (GO:2000811) | 2.25350788 |
| 165 | positive regulation of heat generation (GO:0031652) | 2.25197467 |
| 166 | regulation of fever generation (GO:0031620) | 2.25061603 |
| 167 | mannose metabolic process (GO:0006013) | 2.24966320 |
| 168 | macrophage activation involved in immune response (GO:0002281) | 2.24828028 |
| 169 | regulation of podosome assembly (GO:0071801) | 2.23367103 |
| 170 | stress fiber assembly (GO:0043149) | 2.22692846 |
| 171 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.22027051 |
| 172 | surfactant homeostasis (GO:0043129) | 2.21527366 |
| 173 | regulation of T-helper cell differentiation (GO:0045622) | 2.20326332 |
| 174 | decidualization (GO:0046697) | 2.19934797 |
| 175 | positive regulation of interferon-beta production (GO:0032728) | 2.19893043 |
| 176 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.19867331 |
| 177 | negative regulation of lipid storage (GO:0010888) | 2.19528551 |
| 178 | mammary gland epithelial cell proliferation (GO:0033598) | 2.18539502 |
| 179 | regulation of anoikis (GO:2000209) | 2.17956492 |
| 180 | wound healing, spreading of epidermal cells (GO:0035313) | 2.17159732 |
| 181 | negative regulation of fatty acid transport (GO:2000192) | 2.16749894 |
| 182 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.16189075 |
| 183 | defense response to protozoan (GO:0042832) | 2.15975801 |
| 184 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.15944548 |
| 185 | pericardium development (GO:0060039) | 2.14700199 |
| 186 | T-helper 1 type immune response (GO:0042088) | 2.13512752 |
| 187 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.13169753 |
| 188 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.12929660 |
| 189 | positive regulation of interleukin-6 production (GO:0032755) | 2.11486034 |
| 190 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.10696611 |
| 191 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.10672133 |
| 192 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.09445735 |
| 193 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.08821126 |
| 194 | cellular response to lipopolysaccharide (GO:0071222) | 2.08725996 |
| 195 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.08616964 |
| 196 | positive regulation of astrocyte differentiation (GO:0048711) | 2.08070602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.31321461 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.71184068 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.23860082 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.53203775 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.98525666 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88773361 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84539074 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75680107 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.49083252 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44777415 |
| 11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.42676942 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.42215471 |
| 13 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.33638117 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31589192 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19547588 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.17203559 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09513896 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.08861286 |
| 19 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.97628784 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95109767 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94656946 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.94521542 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.93798415 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93202234 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92191096 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89226647 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82964599 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79109339 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72953790 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67815890 |
| 31 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65627914 |
| 32 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64957622 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63178333 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60777303 |
| 35 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59039298 |
| 36 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.58894555 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57815186 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57323740 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57169954 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57052714 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55382858 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53410280 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50881809 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47796397 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46795750 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45150756 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41767555 |
| 48 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40992222 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39500004 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39497729 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36058378 |
| 52 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35894593 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35571270 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34889470 |
| 55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34564949 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34564949 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33827644 |
| 58 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.33817341 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32696376 |
| 60 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32535211 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32489637 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31624680 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30540123 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29258105 |
| 65 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.29036458 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28832820 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27727698 |
| 68 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26933319 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26266441 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25822818 |
| 71 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25818993 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25329365 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23793635 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21796787 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21132246 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18932428 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18856697 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17139919 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17091158 |
| 80 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16889778 |
| 81 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15829714 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14466248 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13304198 |
| 84 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10683503 |
| 85 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10470490 |
| 86 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10131482 |
| 87 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10131482 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10099739 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10017663 |
| 90 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09244023 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09106816 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08722392 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08617958 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07884382 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07790747 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07260069 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06082880 |
| 98 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05575018 |
| 99 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05206700 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05125997 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04957715 |
| 102 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04956685 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04261670 |
| 104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03017791 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02598226 |
| 106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02340966 |
| 107 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01036483 |
| 108 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01036483 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99488396 |
| 110 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98731886 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98713002 |
| 112 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97549554 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.97423705 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96696403 |
| 115 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94320354 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93910174 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93678115 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93492992 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92451150 |
| 120 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92212454 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91311295 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91056051 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90591531 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 0.90093415 |
| 125 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.89640755 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89326736 |
| 127 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88863857 |
| 128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88696055 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88675478 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87745290 |
| 131 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.83753814 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.83430205 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83157414 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.82412612 |
| 135 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.82412612 |
| 136 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.82412612 |
| 137 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.81757052 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81328817 |
| 139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81302359 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81103932 |
| 141 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80666716 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79702546 |
| 143 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.79450225 |
| 144 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.79104642 |
| 145 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78264407 |
| 146 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78222451 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77796893 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.77182335 |
| 149 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76666699 |
| 150 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.76479005 |
| 151 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.75999111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 3.46485540 |
| 2 | MP0005451_abnormal_body_composition | 3.32491247 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.67874246 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.67310416 |
| 5 | MP0003646_muscle_fatigue | 2.60900560 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.53485971 |
| 7 | MP0003718_maternal_effect | 2.52690581 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.46036716 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.15938925 |
| 10 | MP0009840_abnormal_foam_cell | 2.08097084 |
| 11 | MP0006054_spinal_hemorrhage | 2.03687302 |
| 12 | MP0003724_increased_susceptibility_to | 2.03427393 |
| 13 | MP0003077_abnormal_cell_cycle | 2.03260285 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.02207823 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 1.97258185 |
| 16 | MP0010094_abnormal_chromosome_stability | 1.92901788 |
| 17 | MP0010307_abnormal_tumor_latency | 1.88386085 |
| 18 | MP0005275_abnormal_skin_tensile | 1.84719994 |
| 19 | MP0005408_hypopigmentation | 1.80702698 |
| 20 | MP0003111_abnormal_nucleus_morphology | 1.78459477 |
| 21 | MP0008877_abnormal_DNA_methylation | 1.76796154 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.76688609 |
| 23 | MP0001851_eye_inflammation | 1.75385465 |
| 24 | * MP0001119_abnormal_female_reproductive | 1.71219743 |
| 25 | MP0008057_abnormal_DNA_replication | 1.70753233 |
| 26 | MP0003448_altered_tumor_morphology | 1.68646600 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.67803337 |
| 28 | MP0008004_abnormal_stomach_pH | 1.64674291 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.62627386 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.59619508 |
| 31 | MP0000490_abnormal_crypts_of | 1.49161864 |
| 32 | MP0005395_other_phenotype | 1.46723641 |
| 33 | MP0003123_paternal_imprinting | 1.45158732 |
| 34 | MP0003436_decreased_susceptibility_to | 1.43185089 |
| 35 | MP0003828_pulmonary_edema | 1.42016171 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.41535044 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.41327828 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.40851177 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.39727033 |
| 40 | MP0003303_peritoneal_inflammation | 1.37716278 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.36256794 |
| 42 | MP0002405_respiratory_system_inflammati | 1.34338367 |
| 43 | MP0009785_altered_susceptibility_to | 1.33864844 |
| 44 | MP0002419_abnormal_innate_immunity | 1.33131697 |
| 45 | MP0002006_tumorigenesis | 1.33092401 |
| 46 | MP0000685_abnormal_immune_system | 1.32597027 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.31136934 |
| 48 | MP0001542_abnormal_bone_strength | 1.30567032 |
| 49 | MP0000858_altered_metastatic_potential | 1.30478518 |
| 50 | MP0004272_abnormal_basement_membrane | 1.27063795 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.26953719 |
| 52 | MP0003045_fibrosis | 1.26171052 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.24449313 |
| 54 | MP0003091_abnormal_cell_migration | 1.24367955 |
| 55 | MP0003937_abnormal_limbs/digits/tail_de | 1.21456846 |
| 56 | MP0005023_abnormal_wound_healing | 1.21068704 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.19954266 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.18450153 |
| 59 | MP0003787_abnormal_imprinting | 1.18390799 |
| 60 | MP0004510_myositis | 1.17726213 |
| 61 | MP0005310_abnormal_salivary_gland | 1.17503350 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.16906252 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.16834133 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.16451031 |
| 65 | * MP0003699_abnormal_female_reproductive | 1.16249858 |
| 66 | MP0000343_altered_response_to | 1.15453293 |
| 67 | MP0001915_intracranial_hemorrhage | 1.14402871 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 1.13744653 |
| 69 | * MP0005390_skeleton_phenotype | 1.13643614 |
| 70 | MP0003075_altered_response_to | 1.12905264 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.12518753 |
| 72 | MP0001545_abnormal_hematopoietic_system | 1.12518753 |
| 73 | MP0001800_abnormal_humoral_immune | 1.12432230 |
| 74 | MP0005387_immune_system_phenotype | 1.11367793 |
| 75 | MP0001790_abnormal_immune_system | 1.11367793 |
| 76 | MP0003786_premature_aging | 1.10886782 |
| 77 | MP0000350_abnormal_cell_proliferation | 1.09821691 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.09713427 |
| 79 | MP0000566_synostosis | 1.08218722 |
| 80 | MP0002210_abnormal_sex_determination | 1.08112795 |
| 81 | MP0003279_aneurysm | 1.07623355 |
| 82 | MP0005165_increased_susceptibility_to | 1.07522241 |
| 83 | MP0001853_heart_inflammation | 1.06160580 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.04819578 |
| 85 | MP0001958_emphysema | 1.03167397 |
| 86 | MP0002723_abnormal_immune_serum | 1.02612350 |
| 87 | MP0009764_decreased_sensitivity_to | 1.02411182 |
| 88 | MP0001348_abnormal_lacrimal_gland | 1.01987600 |
| 89 | MP0003566_abnormal_cell_adhesion | 1.01987378 |
| 90 | MP0005257_abnormal_intraocular_pressure | 1.01486906 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.99740969 |
| 92 | MP0001819_abnormal_immune_cell | 0.99253082 |
| 93 | MP0002009_preneoplasia | 0.97977178 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.97969090 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.97390357 |
| 96 | * MP0000767_abnormal_smooth_muscle | 0.97269336 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.96882447 |
| 98 | * MP0000653_abnormal_sex_gland | 0.96604065 |
| 99 | MP0000627_abnormal_mammary_gland | 0.96437560 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.96135903 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.95893582 |
| 102 | * MP0001845_abnormal_inflammatory_respons | 0.95706304 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.94972945 |
| 104 | MP0005166_decreased_susceptibility_to | 0.94697447 |
| 105 | * MP0005508_abnormal_skeleton_morphology | 0.94544568 |
| 106 | MP0004947_skin_inflammation | 0.94050563 |
| 107 | MP0003136_yellow_coat_color | 0.93668815 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.93548811 |
| 109 | MP0005164_abnormal_response_to | 0.93318429 |
| 110 | MP0005025_abnormal_response_to | 0.92365851 |
| 111 | MP0002933_joint_inflammation | 0.91975198 |
| 112 | MP0003950_abnormal_plasma_membrane | 0.91738184 |
| 113 | MP0006082_CNS_inflammation | 0.91535576 |
| 114 | MP0000733_abnormal_muscle_development | 0.90816226 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.90622858 |
| 116 | MP0003941_abnormal_skin_development | 0.90564458 |
| 117 | MP0002282_abnormal_trachea_morphology | 0.90313325 |
| 118 | MP0004883_abnormal_blood_vessel | 0.89353041 |
| 119 | MP0002060_abnormal_skin_morphology | 0.88928299 |
| 120 | MP0002168_other_aberrant_phenotype | 0.88465934 |
| 121 | MP0008058_abnormal_DNA_repair | 0.88447461 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.87862138 |
| 123 | MP0002796_impaired_skin_barrier | 0.87846207 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.87709620 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.86473818 |
| 126 | MP0001929_abnormal_gametogenesis | 0.86192463 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.85989783 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.85927171 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.85847683 |
| 130 | MP0001243_abnormal_dermal_layer | 0.85377293 |
| 131 | MP0000427_abnormal_hair_cycle | 0.84925439 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.84583357 |
| 133 | MP0005621_abnormal_cell_physiology | 0.84136942 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.82959092 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.82674833 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.81754393 |
| 137 | MP0001191_abnormal_skin_condition | 0.80896478 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.80874294 |
| 139 | MP0009278_abnormal_bone_marrow | 0.80745170 |
| 140 | MP0008469_abnormal_protein_level | 0.79588829 |
| 141 | MP0000249_abnormal_blood_vessel | 0.78202209 |
| 142 | MP0003795_abnormal_bone_structure | 0.76503789 |
| 143 | MP0000383_abnormal_hair_follicle | 0.76455101 |
| 144 | MP0002896_abnormal_bone_mineralization | 0.75357617 |
| 145 | MP0005409_darkened_coat_color | 0.73953241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 4.52574422 |
| 2 | Optic neuritis (HP:0100653) | 4.28178572 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.28178572 |
| 4 | Chromsome breakage (HP:0040012) | 3.91411653 |
| 5 | Flat capital femoral epiphysis (HP:0003370) | 3.83639418 |
| 6 | Orchitis (HP:0100796) | 3.78835259 |
| 7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.56535094 |
| 8 | Myositis (HP:0100614) | 3.40261217 |
| 9 | Aortic aneurysm (HP:0004942) | 3.39634523 |
| 10 | Atrophic scars (HP:0001075) | 3.28679570 |
| 11 | Male infertility (HP:0003251) | 3.21095093 |
| 12 | Papillary thyroid carcinoma (HP:0002895) | 3.08336552 |
| 13 | Premature rupture of membranes (HP:0001788) | 3.07422377 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04099836 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04099836 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04099836 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.02340902 |
| 18 | Follicular hyperkeratosis (HP:0007502) | 2.99991396 |
| 19 | Adrenal hypoplasia (HP:0000835) | 2.98726079 |
| 20 | Osteolytic defects of the hand bones (HP:0009699) | 2.98226372 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.98226372 |
| 22 | Thick nail (HP:0001805) | 2.97499391 |
| 23 | Acute myeloid leukemia (HP:0004808) | 2.94323449 |
| 24 | Capillary hemangiomas (HP:0005306) | 2.88102493 |
| 25 | Lip pit (HP:0100267) | 2.83637026 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.79791911 |
| 27 | Birth length less than 3rd percentile (HP:0003561) | 2.76992646 |
| 28 | Aortic dissection (HP:0002647) | 2.74372649 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.73999379 |
| 30 | Abnormality of the fingertips (HP:0001211) | 2.73968352 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.72716171 |
| 32 | Milia (HP:0001056) | 2.71051760 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.64727372 |
| 34 | Spondylolisthesis (HP:0003302) | 2.63071981 |
| 35 | Onycholysis (HP:0001806) | 2.60416539 |
| 36 | Spinal cord lesions (HP:0100561) | 2.56387975 |
| 37 | Syringomyelia (HP:0003396) | 2.56387975 |
| 38 | Alopecia of scalp (HP:0002293) | 2.56092192 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.54941975 |
| 40 | Irregular epiphyses (HP:0010582) | 2.46106144 |
| 41 | Facial hemangioma (HP:0000329) | 2.44913345 |
| 42 | Natal tooth (HP:0000695) | 2.44364515 |
| 43 | Abnormality of nail color (HP:0100643) | 2.42587408 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.42210519 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.40794991 |
| 46 | Breast hypoplasia (HP:0003187) | 2.35482265 |
| 47 | Keratoconjunctivitis (HP:0001096) | 2.28019491 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.25767388 |
| 49 | Plantar hyperkeratosis (HP:0007556) | 2.23999015 |
| 50 | Loss of speech (HP:0002371) | 2.23886384 |
| 51 | Dilatation of the ascending aorta (HP:0005111) | 2.23344312 |
| 52 | Tetraparesis (HP:0002273) | 2.22713916 |
| 53 | Arterial tortuosity (HP:0005116) | 2.22270141 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.21776370 |
| 55 | Shawl scrotum (HP:0000049) | 2.21352157 |
| 56 | Subacute progressive viral hepatitis (HP:0006572) | 2.13648382 |
| 57 | Arterial thrombosis (HP:0004420) | 2.12862128 |
| 58 | Xerostomia (HP:0000217) | 2.11949289 |
| 59 | Abnormality of chromosome stability (HP:0003220) | 2.10800692 |
| 60 | Patellar aplasia (HP:0006443) | 2.10145401 |
| 61 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.09343641 |
| 62 | Breast aplasia (HP:0100783) | 2.08976169 |
| 63 | Wormian bones (HP:0002645) | 2.08349727 |
| 64 | Abnormality of incisor morphology (HP:0011063) | 2.07971465 |
| 65 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.07632263 |
| 66 | Abnormality of femoral epiphyses (HP:0006499) | 2.07632263 |
| 67 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.05588204 |
| 68 | Hypoplasia of the fovea (HP:0007750) | 2.05588204 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.05292487 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.04650031 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.04608594 |
| 72 | Myocardial infarction (HP:0001658) | 2.04398089 |
| 73 | Oligodactyly (hands) (HP:0001180) | 2.03688090 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.03110283 |
| 75 | Vascular tortuosity (HP:0004948) | 2.02251894 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01934263 |
| 77 | Aneurysm (HP:0002617) | 2.01348243 |
| 78 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.01334155 |
| 79 | Entropion (HP:0000621) | 2.00858777 |
| 80 | Anhidrosis (HP:0000970) | 2.00129865 |
| 81 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.98769907 |
| 82 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.98445024 |
| 83 | Abnormality of the femoral head (HP:0003368) | 1.97561127 |
| 84 | Abnormality of macrophages (HP:0004311) | 1.97059888 |
| 85 | Fragile skin (HP:0001030) | 1.96296326 |
| 86 | Thoracolumbar scoliosis (HP:0002944) | 1.95785140 |
| 87 | Aseptic necrosis (HP:0010885) | 1.95694631 |
| 88 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.93561696 |
| 89 | Abnormality of male internal genitalia (HP:0000022) | 1.91808074 |
| 90 | Cervical subluxation (HP:0003308) | 1.89086470 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 1.88442804 |
| 92 | Delayed epiphyseal ossification (HP:0002663) | 1.88410017 |
| 93 | Abnormality of the nasal septum (HP:0000419) | 1.88301640 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 1.87385060 |
| 95 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.86068402 |
| 96 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.86059036 |
| 97 | Nail dystrophy (HP:0008404) | 1.85506917 |
| 98 | Ectopic kidney (HP:0000086) | 1.85453786 |
| 99 | Glucose intolerance (HP:0000833) | 1.84421597 |
| 100 | Elbow flexion contracture (HP:0002987) | 1.84056367 |
| 101 | Stomatitis (HP:0010280) | 1.83969122 |
| 102 | Thyroid carcinoma (HP:0002890) | 1.83934123 |
| 103 | Ankyloglossia (HP:0010296) | 1.83561084 |
| 104 | Hypoplasia of the iris (HP:0007676) | 1.83039066 |
| 105 | Epiphyseal dysplasia (HP:0002656) | 1.82388762 |
| 106 | Mitral stenosis (HP:0001718) | 1.81663119 |
| 107 | Cystic hygroma (HP:0000476) | 1.81036523 |
| 108 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80705069 |
| 109 | Aplasia cutis congenita (HP:0001057) | 1.80317061 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80121111 |
| 111 | Mucopolysacchariduria (HP:0008155) | 1.80121111 |
| 112 | Carpal bone hypoplasia (HP:0001498) | 1.80033338 |
| 113 | Abnormality of the fovea (HP:0000493) | 1.79127496 |
| 114 | Clubbing of toes (HP:0100760) | 1.78217529 |
| 115 | Spinal rigidity (HP:0003306) | 1.78139655 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 1.78121391 |
| 117 | Short nail (HP:0001799) | 1.77728390 |
| 118 | Oligodactyly (HP:0012165) | 1.77455782 |
| 119 | Cubitus valgus (HP:0002967) | 1.76802476 |
| 120 | Palmoplantar hyperkeratosis (HP:0000972) | 1.76244698 |
| 121 | Stillbirth (HP:0003826) | 1.74915562 |
| 122 | Exocrine pancreatic insufficiency (HP:0001738) | 1.74253410 |
| 123 | Enlarged epiphyses (HP:0010580) | 1.74220538 |
| 124 | Hypoplastic iliac wings (HP:0002866) | 1.73672050 |
| 125 | Hypergonadotropic hypogonadism (HP:0000815) | 1.72146515 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71094026 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71094026 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71094026 |
| 129 | Periodontitis (HP:0000704) | 1.70706447 |
| 130 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.70362312 |
| 131 | Microglossia (HP:0000171) | 1.69747004 |
| 132 | Absent frontal sinuses (HP:0002688) | 1.69671860 |
| 133 | Malnutrition (HP:0004395) | 1.69555114 |
| 134 | Abnormality of oral frenula (HP:0000190) | 1.68884418 |
| 135 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.68720627 |
| 136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67379918 |
| 137 | Abnormality of the labia minora (HP:0012880) | 1.66947638 |
| 138 | Corneal dystrophy (HP:0001131) | 1.66815616 |
| 139 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.66630069 |
| 140 | Vascular calcification (HP:0004934) | 1.66497591 |
| 141 | Nuclear cataract (HP:0100018) | 1.66490476 |
| 142 | Stomach cancer (HP:0012126) | 1.66068176 |
| 143 | Hypoplastic ischia (HP:0003175) | 1.64568250 |
| 144 | Hematochezia (HP:0002573) | 1.64424921 |
| 145 | Pulmonary fibrosis (HP:0002206) | 1.63980212 |
| 146 | Abnormality of lateral ventricle (HP:0030047) | 1.63697389 |
| 147 | Aortic regurgitation (HP:0001659) | 1.63470949 |
| 148 | Ridged nail (HP:0001807) | 1.63153726 |
| 149 | Increased CSF protein (HP:0002922) | 1.63078122 |
| 150 | Abnormal blistering of the skin (HP:0008066) | 1.62896704 |
| 151 | Sparse lateral eyebrow (HP:0005338) | 1.62780688 |
| 152 | Distal lower limb muscle weakness (HP:0009053) | 1.62099375 |
| 153 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.61338798 |
| 154 | Myelodysplasia (HP:0002863) | 1.61144791 |
| 155 | Vitreoretinal degeneration (HP:0000655) | 1.60895392 |
| 156 | Abnormality of the preputium (HP:0100587) | 1.60884990 |
| 157 | Small epiphyses (HP:0010585) | 1.60872254 |
| 158 | Recurrent viral infections (HP:0004429) | 1.60402508 |
| 159 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.59714361 |
| 160 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.59352709 |
| 161 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.59337532 |
| 162 | Genu varum (HP:0002970) | 1.59221892 |
| 163 | Palmar hyperkeratosis (HP:0010765) | 1.58756129 |
| 164 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.58526963 |
| 165 | Overgrowth (HP:0001548) | 1.58402214 |
| 166 | Advanced eruption of teeth (HP:0006288) | 1.58177473 |
| 167 | Meckel diverticulum (HP:0002245) | 1.58174317 |
| 168 | Fatigue (HP:0012378) | 1.58091242 |
| 169 | Blepharitis (HP:0000498) | 1.57107634 |
| 170 | Relative macrocephaly (HP:0004482) | 1.57106883 |
| 171 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.56812140 |
| 172 | Mitral valve prolapse (HP:0001634) | 1.55865541 |
| 173 | Anorexia (HP:0002039) | 1.52600047 |
| 174 | Aplasia of the phalanges of the hand (HP:0009802) | 1.51627965 |
| 175 | Aplasia involving bones of the extremities (HP:0009825) | 1.51627965 |
| 176 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.51627965 |
| 177 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.50681377 |
| 178 | Ectropion (HP:0000656) | 1.49501851 |
| 179 | Cupped ribs (HP:0000887) | 1.49131656 |
| 180 | Abnormality of chromosome segregation (HP:0002916) | 1.48536340 |
| 181 | Azoospermia (HP:0000027) | 1.47864405 |
| 182 | Metaphyseal irregularity (HP:0003025) | 1.47607226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.33816614 |
| 2 | STK38L | 3.39186527 |
| 3 | PLK4 | 3.21488501 |
| 4 | ERBB4 | 3.11247048 |
| 5 | MUSK | 2.98402791 |
| 6 | LATS2 | 2.96273912 |
| 7 | AKT3 | 2.93826996 |
| 8 | EIF2AK3 | 2.77550318 |
| 9 | PRPF4B | 2.68390942 |
| 10 | MAP3K6 | 2.48802884 |
| 11 | STK3 | 2.26624521 |
| 12 | TGFBR2 | 2.20456433 |
| 13 | KSR2 | 2.19818553 |
| 14 | MST1R | 2.16929740 |
| 15 | RAF1 | 1.97329585 |
| 16 | TRPM7 | 1.95327722 |
| 17 | CDC7 | 1.91416517 |
| 18 | MAP3K14 | 1.86843354 |
| 19 | MAP3K13 | 1.85137510 |
| 20 | BMPR2 | 1.84149117 |
| 21 | MOS | 1.82067849 |
| 22 | TAOK1 | 1.81513681 |
| 23 | GRK7 | 1.77897566 |
| 24 | CDK9 | 1.76160757 |
| 25 | TAOK3 | 1.73843957 |
| 26 | JAK3 | 1.73725475 |
| 27 | BRAF | 1.71457486 |
| 28 | MST4 | 1.68913346 |
| 29 | TTK | 1.62988584 |
| 30 | NUAK1 | 1.61190660 |
| 31 | IRAK3 | 1.56747849 |
| 32 | DDR2 | 1.51838740 |
| 33 | MAPKAPK5 | 1.50355224 |
| 34 | PDGFRA | 1.49971733 |
| 35 | MELK | 1.49123196 |
| 36 | EEF2K | 1.48608908 |
| 37 | PBK | 1.44709539 |
| 38 | EPHA3 | 1.44304920 |
| 39 | PIM2 | 1.41854080 |
| 40 | ACVR1B | 1.39845807 |
| 41 | MET | 1.38907152 |
| 42 | CDK8 | 1.38441304 |
| 43 | TAOK2 | 1.38193787 |
| 44 | MAPKAPK3 | 1.36954898 |
| 45 | CHUK | 1.36155925 |
| 46 | SIK3 | 1.36129517 |
| 47 | IKBKE | 1.32102366 |
| 48 | PDK2 | 1.29580430 |
| 49 | STK24 | 1.29520240 |
| 50 | TXK | 1.28549713 |
| 51 | BMPR1B | 1.25260046 |
| 52 | IKBKB | 1.22357400 |
| 53 | FRK | 1.22253846 |
| 54 | ERN1 | 1.18937845 |
| 55 | KSR1 | 1.17131125 |
| 56 | ABL2 | 1.13552118 |
| 57 | PIM1 | 1.13512587 |
| 58 | MKNK1 | 1.11950236 |
| 59 | PTK2 | 1.11028996 |
| 60 | STK10 | 1.09316561 |
| 61 | NEK9 | 1.08171128 |
| 62 | ARAF | 1.07625710 |
| 63 | BRD4 | 1.05840747 |
| 64 | DMPK | 1.02560817 |
| 65 | RPS6KA4 | 1.01709051 |
| 66 | NLK | 1.01581362 |
| 67 | IRAK1 | 0.98797770 |
| 68 | EPHB1 | 0.97415729 |
| 69 | MKNK2 | 0.96170330 |
| 70 | MAP2K3 | 0.95524399 |
| 71 | DYRK2 | 0.95352805 |
| 72 | TTN | 0.95070163 |
| 73 | MAP3K5 | 0.94406530 |
| 74 | NEK2 | 0.92552620 |
| 75 | LMTK2 | 0.92460339 |
| 76 | MYLK | 0.91422138 |
| 77 | CHEK2 | 0.90738977 |
| 78 | CDK3 | 0.85629507 |
| 79 | TBK1 | 0.85381322 |
| 80 | PAK2 | 0.83949259 |
| 81 | MAP3K1 | 0.82589541 |
| 82 | ZAK | 0.80354359 |
| 83 | MAP3K9 | 0.79842889 |
| 84 | MAP3K3 | 0.79025230 |
| 85 | CDK12 | 0.78575262 |
| 86 | ZAP70 | 0.75383750 |
| 87 | RPS6KB2 | 0.74145266 |
| 88 | PLK1 | 0.73976264 |
| 89 | MAPK7 | 0.73403116 |
| 90 | MAP3K2 | 0.73212423 |
| 91 | YES1 | 0.73128140 |
| 92 | CDC42BPA | 0.72695949 |
| 93 | SIK1 | 0.72515184 |
| 94 | TYK2 | 0.71512664 |
| 95 | AURKB | 0.69797549 |
| 96 | WEE1 | 0.68666103 |
| 97 | STK38 | 0.68362247 |
| 98 | CSK | 0.68307468 |
| 99 | ABL1 | 0.67481620 |
| 100 | PLK3 | 0.66999905 |
| 101 | PIK3CG | 0.66634706 |
| 102 | STK4 | 0.66606754 |
| 103 | FER | 0.65371562 |
| 104 | MARK3 | 0.65005762 |
| 105 | ERBB3 | 0.64248815 |
| 106 | RIPK1 | 0.64147071 |
| 107 | CLK1 | 0.63566351 |
| 108 | ICK | 0.63422715 |
| 109 | MTOR | 0.63131205 |
| 110 | FGFR3 | 0.60674264 |
| 111 | GSK3A | 0.60150983 |
| 112 | FLT3 | 0.59514287 |
| 113 | PAK4 | 0.56458345 |
| 114 | TEC | 0.56134648 |
| 115 | PRKD2 | 0.55728522 |
| 116 | MAP3K8 | 0.54988543 |
| 117 | MAP3K12 | 0.54632698 |
| 118 | EIF2AK2 | 0.53810145 |
| 119 | SGK3 | 0.52882221 |
| 120 | JAK1 | 0.51941153 |
| 121 | BLK | 0.51711743 |
| 122 | IRAK2 | 0.51322290 |
| 123 | BRSK2 | 0.50209700 |
| 124 | CDK6 | 0.47439492 |
| 125 | HCK | 0.47258099 |
| 126 | TRIB3 | 0.47049065 |
| 127 | ATM | 0.45585758 |
| 128 | RIPK4 | 0.45541105 |
| 129 | CDK7 | 0.44655058 |
| 130 | VRK1 | 0.44453512 |
| 131 | CDK4 | 0.43854771 |
| 132 | PRKAA2 | 0.43090472 |
| 133 | INSR | 0.43028561 |
| 134 | MAPKAPK2 | 0.42913391 |
| 135 | CSF1R | 0.42584003 |
| 136 | RPS6KA5 | 0.42249439 |
| 137 | EPHA2 | 0.41357843 |
| 138 | SGK2 | 0.40633223 |
| 139 | JAK2 | 0.39478013 |
| 140 | HIPK2 | 0.39423493 |
| 141 | PAK6 | 0.38141189 |
| 142 | IRAK4 | 0.37708786 |
| 143 | TGFBR1 | 0.37144943 |
| 144 | ATR | 0.35226525 |
| 145 | CHEK1 | 0.34719012 |
| 146 | NEK6 | 0.32924465 |
| 147 | DYRK3 | 0.32239245 |
| 148 | KIT | 0.32042151 |
| 149 | PDGFRB | 0.32026345 |
| 150 | MAP4K1 | 0.31939950 |
| 151 | BUB1 | 0.31747084 |
| 152 | MAP2K1 | 0.30112525 |
| 153 | BMX | 0.28666257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cell cycle_Homo sapiens_hsa04110 | 2.48042458 |
| 2 | RNA degradation_Homo sapiens_hsa03018 | 2.01025863 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98474813 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.93451642 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89684718 |
| 6 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.89270883 |
| 7 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.89130877 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 1.85340154 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79585240 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.75262005 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.74391951 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74228105 |
| 13 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.68134548 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.66915645 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.65103555 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62902915 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58982160 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50877605 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45885969 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.43040359 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.39927379 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38958234 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.38319187 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.38130216 |
| 25 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37153176 |
| 26 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.31917912 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.25428464 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24977562 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23792775 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23420495 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23034543 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22383273 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.22254304 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22176839 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.19055338 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17778809 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.16308784 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.15276434 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14630919 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13374245 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11077052 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09057304 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07111568 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 1.05185847 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.04033754 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03550120 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.02372709 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.01303766 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01273050 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01231028 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99659446 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98605514 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98492061 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98437275 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98146587 |
| 56 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.97713898 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96803761 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.94625425 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.93839679 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89429575 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88650654 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88024467 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87779575 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87464316 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.86855954 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86024753 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 0.85826771 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85689420 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.85687165 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85460603 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84794958 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83215221 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82049946 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.82035848 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81736075 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81405270 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81074413 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80982394 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.80175418 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79897012 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.77712204 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76364553 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76096532 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76064495 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75809939 |
| 86 | Mismatch repair_Homo sapiens_hsa03430 | 0.73914706 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.73786203 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73776300 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73011529 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.72281046 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71105281 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70950934 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70690021 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.70409410 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.69759742 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69507511 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69320477 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68900808 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67821019 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67710018 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67067703 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66731875 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66554610 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65078706 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64174659 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63121644 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62905064 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.62676388 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61850211 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61511068 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61482933 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.61473185 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60216813 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59921308 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.59878067 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59426768 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58700397 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58052047 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57888489 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.57853737 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57839662 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57782716 |
| 123 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57165162 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56399041 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56032154 |
| 126 | Melanoma_Homo sapiens_hsa05218 | 0.54417560 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53035088 |

